Study of CP-675,206 in Refractory Melanoma

PHASE2CompletedINTERVENTIONAL
Enrollment

251

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Refractory Melanoma
Interventions
DRUG

CP-675,206

15 mg/kg Q12W dosing regimen

Trial Locations (65)

2145

Research Site, Westmead

2298

Research Site, Waratah

3002

Research Site, East Melbourne

4102

Research Site, Woolloongabba

6009

Research Site, Nedlands

10016

Research Site, New York

10117

Research Site, Berlin

14263

Research Site, Buffalo

15232

Research Site, Pittsburgh

18015

Research Site, Bethlehem

20132

Research Site, Milan

20133

Research Site, Milan

20141

Research Site, Milan

24105

Research Site, Kiel

27710

Research Site, Durham

28046

Research Site, Madrid

31008

Research Site, Pamplona

32803

Research Site, Orlando

32804

Research Site, Orlando

34761

Research Site, Ocoee

37232

Research Site, Nashville

40202

Research Site, Louisville

43210

Pfizer Investigational Site, Columbus

Research Site, Columbus

46202

Research Site, Indianapolis

46237

Research Site, Indianapolis

46260

Research Site, Indianapolis

47014

Research Site, Meldola, FC

50009

Research Site, Zaragoza

53792

Research Site, Madison

59037

Research Site, Lille

60488

Research Site, Frankfurt

60637

Research Site, Chicago

72076

Research Site, Tübingen

72205

Research Site, Little Rock

72703

Research Site, Fayetteville

72712

Research Site, Bentonville

75651

Research Site, Paris

80045

Research Site, Aurora

84112

Research Site, Salt Lake City

85260

Research Site, Scottsdale

90095

Research Site, Los Angeles

94805

Research Site, Villejuif

98003

Research Site, Federal Way

98104

Research Site, Seattle

98122

Research Site, Seattle

98405

Research Site, Tacoma

98499

Research Site, Lakewood

90095-6970

Research Site, Los Angeles

06902-3628

Research Site, Stamford

21237-3998

Research Site, Baltimore

02215

Research Site, Boston

48109-0946

Research Site, Ann Arbor

27599-7600

Research Site, Chapel Hill

37232-6307

Research Site, Nashville

C1280AEA

Research Site, Ciudad de Buenos Aires

L8V 5C2

Research Site, Hamilton

08036

Research Site, Barcelona

TR1 3LJ

Research Site, Truro

HA6 2RN

Research Site, Northwood

SM2 5PT

Research Site, Sutton

NE4 6BE

Research Site, Newcastle upon Tyne

SW3 6JJ

Research Site, London

M20 4BX

Research Site, Manchester

NE7 7DN

Research Site, Newcastle upon Tyne

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY